The EXPERTS Act of 2025 overhauls several parts of the Administrative Procedure Act to force greater transparency about who funds, reviews, or stands to benefit from studies and research submitted during rulemaking. It requires interested persons to disclose funding sources, reviewer involvement, and financial relationships for non‑peer‑reviewed work; directs agencies to post such materials on public dockets and flag ‘‘conflicts’’ (including when 10% or more of funding comes from an entity within the agency’s jurisdiction); and permits agencies to exclude submissions that fail to comply.
Beyond disclosure, the bill creates an Office of the Public Advocate with a presidentially appointed National Public Advocate tasked with boosting public participation and conducting social equity assessments on request; narrows ‘‘negotiated rulemaking’’ to intergovernmental negotiation; imposes a 60‑day (plus one 30‑day) OIRA review limit for significant rules; creates civil penalties for public companies that knowingly submit materially false information; and provides a fast‑track route to reinstate previously disapproved rules. Those changes shift evidentiary expectations for agency dockets, accelerate some review timelines, and introduce new procedural levers that will matter to agencies, regulated entities, researchers, and litigators.
At a Glance
What It Does
The bill requires detailed disclosures about funding, sponsorship, reviewer access, and financial ties when an interested person submits scientific, economic, or technical studies (especially unpublished work) in rulemaking. It mandates public posting of those materials, defines a conflict threshold (10% funding or regulator‑involved review/revision), authorizes agencies to exclude noncompliant submissions, creates the Office of the Public Advocate, and sets stricter OIRA review clocks and new penalties for false filings by public companies.
Who It Affects
Federal agencies that conduct rulemaking and OIRA will face new docketing, notification, and assessment duties; research institutions, consultants, and trade associations that furnish studies to rule dockets must make funding and review relationships public; public companies that participate in rulemaking must preserve and attach recent SEC filings and risk statutory fines for false statements; and State, local, and Tribal governments are reshaped as the primary participants in negotiated rulemaking.
Why It Matters
The Act changes what counts as acceptable evidence in administrative dockets and raises the cost of withholding funding and review information. By tightening OIRA timelines and allowing reinstatement of disapproved rules, it raises the administrative and litigation stakes for agencies and regulated parties, and it institutionalizes social equity analysis as a procedural expectation for rulemaking.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This bill rewrites several practical rules for how agencies collect and publish the studies and technical evidence they receive while writing regulations. When an ‘‘interested person’’ submits research or unpublished results, they must disclose who funded the work, who sponsored it, whether any regulated entity reviewed or revised it, and any financial ties between the researchers and entities affected by the rule.
Agencies must make submitted studies publicly available on their websites and dockets unless a Freedom of Information Act exemption applies, and the agency must flag and publish conflicts when at least 10% of a study’s funding comes from a regulated entity or when a regulated entity reviewed or revised the work.
The bill gives agencies the authority to exclude or disregard submissions that fail to meet these disclosure requirements, while allowing a refiling that includes the required disclosures during the notice‑and‑comment window. It also requires certain corporate filers to attach recent SEC reports to submissions and imposes minimum civil penalties ($250,000 first offense; $1,000,000 for recidivists) when a public company knowingly files materially false or misleading information in a rulemaking submission.
Those provisions aim to make the evidence base more transparent and to deter deceptive submissions.On process, the Act narrows negotiated rulemaking: it repurposes that mechanism to focus on negotiations between federal, State, local, and Tribal governments and removes private parties as the intended primary participants. The Office of Information and Regulatory Affairs is subject to a 60‑day deadline to complete reviews of significant regulatory actions, extendable once for 30 days only with a public written justification; absent timely action (or a waiver), agencies may proceed to publish.
The bill also creates a new Office of the Public Advocate—headed by a Presidential appointee—to increase outreach, run social equity assessments on request within 30 days, and coordinate accessible public participation.Finally, the Act changes litigation and rule stability: it adds a 6‑year statute of limitations to challenges under the APA, instructs courts to defer to agency interpretations when statutes are silent or ambiguous provided agencies followed the bill’s procedures, and allows agencies to republish rules that Congress previously disapproved if the agency republishes within one year of enactment or follows standard notice‑and‑comment thereafter. Those provisions collectively make agency rulemaking records more documentary, speed parts of the administrative calendar, and broaden procedural tools for agencies and stakeholders.
The Five Things You Need to Know
The bill defines a ‘‘conflict’’ that agencies must disclose when a submitted study receives at least 10% of its funding from an entity regulated by the agency or when a regulated entity conducts, reviews, or revises the study.
Agencies must publish submitted studies and related disclosures on their website and public rulemaking dockets unless protected by FOIA, and must publish conflict notices on the docket and in the Federal Register.
Agencies may exclude or disregard submissions that fail to include the statutory disclosures; excluded submissions may be remade only with the required disclosures during the open comment period.
OIRA must complete review of a ‘‘significant regulatory action’’ within 60 days, extendable once for 30 days only if it posts a written justification; if OIRA waives or misses the deadline, the agency may publish the rule.
The Act establishes an Office of the Public Advocate (National Public Advocate appointed by the President) with duties including assisting public participation, coordinating outreach for underrepresented groups, and performing social equity assessments on request within 30 days.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Stronger disclosure and publicization of studies submitted to dockets
These amendments add layered disclosure duties for ‘‘interested persons’’ who submit scientific, economic, or technical studies as part of notice‑and‑comment. Subsection (c)(2) and new subsection (f) require submission of funding amounts, funding sources, sponsorship, whether regulated entities reviewed or revised the work, and any consulting or financial ties between researchers and affected parties. Subsection (g) makes non‑peer‑reviewed studies publicly available on agency websites and dockets subject to FOIA exceptions. Practically, agencies will need updated intake procedures, standardized disclosure forms, and document‑management workflows to capture and publish this metadata.
Conflict definition, public notices, and exclusion authority
The bill defines a reportable ‘‘conflict’’ where at least 10% of study funding comes from a regulated entity or where such an entity reviewed or revised the work. Agencies must post conflict statements on the docket and in the Federal Register. Subsection (i) lets agencies exclude non‑complying submissions and refuse to respond to them; it preserves an opportunity to resubmit with the required disclosures. That exclusion power is administrative (not criminal) but will influence the evidentiary record agencies rely on and potentially the scope of materials courts later review.
Documenting changes after centralized review
Agencies must place in the docket the substance of any changes between drafts they gave OMB and the text published in the notice of proposed rulemaking and again before publication in the Federal Register, together with statements identifying whether changes resulted from communications with OMB, another agency, or any Federal official. This creates a discoverable paper trail for draft comparisons and for tracking outside influence on text—an important evidentiary tool but one that will require agencies to preserve comparative drafts and explanations.
Narrows negotiated rulemaking to intergovernmental negotiation
The bill amends subchapter III to refocus negotiated rulemaking on negotiations between federal, State, local, and Tribal governments. Language that previously emphasized including ‘‘persons’’ or residents is revised to require representatives of governments. The change requires agencies and offices that previously used negotiated rulemaking with stakeholders to reassess whether that mechanism remains available for their subject matter and may trigger conforming edits across statutes where negotiated rulemaking was previously specified.
Shorter OIRA clocks and expanded notice/participation duties
Section 9 caps OIRA review of significant regulatory actions at 60 days with a single 30‑day extension allowed only if OIRA posts a written justification; missing the deadline lets the agency publish. Section 14 requires agencies to notify interested persons within 2 business days of a proposed or final rule’s publication and to keep participation logs for each proceeding. Together these provisions speed up centralized review while increasing immediate outreach and traceability of participants.
Civil penalties for false submissions by public companies and required filings
Public companies required to file under Exchange Act §13 that knowingly submit materially false or misleading statements in rulemaking submissions face minimum civil penalties ($250,000 first offense; $1,000,000 for subsequent). The section also obliges such entities to include their most recent annual and quarterly SEC reports with their submissions, creating a cross‑checkable paper trail and elevating corporate accountability in rule dockets.
New Office of the Public Advocate, deference guidance, extended limitations, and rule reinstatement
Section 11 establishes the Office of the Public Advocate in OMB headed by a National Public Advocate (presidential appointment with Senate consent) charged with outreach, social equity research, and conducting social equity assessments on request within 30 days. Section 12 amends judicial review language to instruct courts to defer to reasonable agency interpretations when statutes are ambiguous if agencies followed the bill’s procedures, and it defines ‘‘unreasonable delay’’ in specific, time‑based terms. Section 13 adds a six‑year statute of limitation for APA challenges. Section 17 allows agencies to republish rules that Congress disapproved if the agency republished within one year of enactment; after that window, standard notice‑and‑comment applies. Those changes collectively affect rule stability, judicial review levers, and administrative timelines.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Underrepresented communities and advocates — The Office of the Public Advocate is charged with outreach, multilingual, plain‑language information, and expedited social equity assessments on request, which should improve participation and surface distributional effects for groups historically excluded from federal rulemaking.
- Agencies seeking procedural defensibility — A more complete public docket that discloses funding and reviewer relationships can strengthen an agency’s administrative record and potentially blunt claims of undisclosed bias, while the deference language and extended statute of limitations favor administrative finality.
- Public interest and health advocates — Greater transparency about who funded or revised studies can help advocates challenge industry‑funded evidence and make it easier to marshal independent science into the record.
- State, local, and Tribal governments — The negotiating framework elevates intergovernmental negotiation channels, giving governments a clearer, prioritized role in negotiated rulemaking processes.
Who Bears the Cost
- Research institutions, consultants, and academic authors — They must disclose funding amounts, sponsors, and review relationships and may be required to place non‑peer‑reviewed results on public dockets, exposing proprietary data or jeopardizing confidentiality and complicating university contracting.
- Trade associations and industry funders — The 10% funding threshold and mandatory disclosure of reviewer involvement increase reputational and litigation risk, and failing to disclose can lead agencies to exclude submissions from consideration.
- Agencies and OMB/OIRA — Agencies must build new intake, publication, and participation‑logging systems, add public‑facing notices and translations, and accommodate 30‑day social equity assessments; OIRA faces compressed review timelines and must publish justifications for extensions.
- Public companies — Corporate filers must attach recent SEC reports to submissions and face steep minimum penalties for knowing false statements, increasing legal exposure and compliance costs.
Key Issues
The Core Tension
The central tension is between transparency and usable expertise: the Act seeks to cleanse rulemaking records of hidden financial influence and improve participation, but its disclosure and publication rules risk chilling researchers’ willingness to submit preliminary or proprietary work and may exclude industry‑funded (but legitimate) studies from consideration—forcing a choice between a cleaner record and a full, diverse evidentiary base for agency decision‑making.
The bill pushes administrative transparency hard; that produces several unresolved implementation questions. First, the disclosure regime removes ambiguity about who funded or touched studies but does not create standards for how agencies should weigh disclosed funding in their substantive analysis.
An agency could publish a conflict flag yet still credit industry‑funded research; conversely, agencies may feel pressure to discount disclosed studies, potentially biasing the evidentiary mix. Second, the requirement to make unpublished studies publicly available collides with common academic and commercial practices around confidentiality, preliminary data, and proprietary methodologies.
Agencies must decide how narrowly to interpret FOIA exemptions to protect trade secrets while complying with the publicization mandate.
Operational trade‑offs are also acute. Narrowing negotiated rulemaking to government representatives reduces one path to consensus that previously involved private stakeholders and community groups; agencies that relied on multi‑stakeholder negotiated procedures will need alternative engagement strategies.
The OIRA 60‑plus‑30‑day limit accelerates timelines but risks compressing review of technically complex rules, with only a single, publicly justified extension permitted. Finally, the statutory language directing courts to defer to agency interpretations where a statute is ambiguous—combined with a longer six‑year limitations period—tilts the balance toward administrative finality and away from short‑term judicial disruption, but it raises questions about how lower courts will reconcile this guidance with existing precedents on Chevron, Auer, and reasonableness review.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.